J Zapletalová
About
In The Last Decade
J Zapletalová
21 papers receiving 121 citations
Peers
Comparison fields: 5 of 45
- Surgery 54
- Oncology 43
- Pathology and Forensic Medicine 18
- Cancer Research 17
- Molecular Biology 15
Countries citing papers authored by J Zapletalová
This map shows the geographic impact of J Zapletalová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Zapletalová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Zapletalová more than expected).
Fields of papers citing papers by J Zapletalová
This network shows the impact of papers produced by J Zapletalová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Zapletalová. The network helps show where J Zapletalová may publish in the future.
Co-authorship network of co-authors of J Zapletalová
This figure shows the co-authorship network connecting the top 25 collaborators of J Zapletalová. A scholar is included among the top collaborators of J Zapletalová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Zapletalová. J Zapletalová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | [The effect of circulating tumor cells on the survival of patients with pancreatic cancer 5-year results]. | 2 |
| 3 | 2 | |
| 4 | 29 | |
| 5 | [Surgical therapy of pancreatic cancer - 5 years survival]. | 2 |
| 6 | [Robot assisted endometrial cancer staging - evaluation the first 100 operations and comparing the first andthe last 30 operations]. | 2 |
| 7 | 2 | |
| 8 | 20 | |
| 9 | 8 | |
| 10 | [Prognostic significance of clinic pathological and selected immunohistochemical factors in endometrial cancer]. | 2 |
| 11 | [18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods]. | 1 |
| 12 | [Immunohistochemical markers expression in hysteroscopy and hysterectomy specimens from endometrial cancer patients: comparison]. | 1 |
| 13 | PML and TRF2 protein expression in hereditary and sporadic colon cancer. | 3 |
| 14 | [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. | 0 |
| 15 | [Is osteolysis associated with a stable total hip replacement asymptomatic?]. | 2 |
| 16 | Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. | 17 |
| 17 | [Validity of bone scintigraphy for the diagnosis of periprosthetic complications in hydroxyapatite-coated total hip arthroplasty]. | 6 |
| 18 | Expression of c-erbB-2 in node negative breast cancer does not correlate with estrogen receptor status, predictors of hormone responsiveness, or PCNA expression. | 8 |
| 19 | Borrelia infection as a cause of carditis (a long-term study). | 8 |
| 20 | [Borrelia burgdorferi as a cause of sick sinus syndrome?]. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.